Edition:
United States

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

3.46USD
2 Dec 2016
Change (% chg)

$-0.08 (-2.26%)
Prev Close
$3.54
Open
$3.50
Day's High
$3.55
Day's Low
$3.40
Volume
8,003
Avg. Vol
6,883
52-wk High
$6.40
52-wk Low
$2.84

ICAD.OQ

Chart for ICAD.OQ

About

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments:... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $57.13
Shares Outstanding(Mil.): 16.05
Dividend: --
Yield (%): --

Financials

  ICAD.OQ Industry Sector
P/E (TTM): -- 15.43 20.15
EPS (TTM): -0.58 -- --
ROI: -28.10 9.63 10.35
ROE: -29.47 13.34 7.90

BRIEF-Harbert Discovery Fund reports 5.01 percent stake in Icad

* Harbert Discovery Fund LP reports 5.01 percent stake in Icad Inc as of Nov. 7 - SEC filing

Nov 07 2016

BRIEF-ICAD Q3 adjusted non-gaap loss per share $0.16

* Says company is not providing financial guidance at this time

Nov 02 2016

BRIEF-iCAD appoints Scott Areglado as interim CFO

* Says appointed R Scott Areglado to serve as interim chief financial officer, interim treasurer and interim secretary - SEC filing Source text for Eikon: Further company coverage:

Sep 08 2016

Earnings vs. Estimates